Mobile

A Multicenter, Randomized, Double-Blind, "Factorial" Design Study to Evaluate the Lipid-Altering Efficacy and Safety of MK-0524B Combination Tablet in Patients With Primary Hypercholesterolemia or Mix...

Update Il y a 5 ans
Reference: EUCTR2005-005094-30

A Multicenter, Randomized, Double-Blind, "Factorial" Design Study to Evaluate the Lipid-Altering Efficacy and Safety of MK-0524B Combination Tablet in Patients With Primary Hypercholesterolemia or Mixed Hyperlipidemia

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

In patients with primary hypercholesterolemia or mixed hyperlipidemia, evaluate: The LDL-C lowering efficacy of MK-0524B 2g (pooled across simvastatin doses of 20 and 40 mg) compared to MK-0524A 2g.

Inclusion criteria

  • Hypercholesterolaemia

Links